Here is a comprehensive breakdown of respiratory droplet vs. aerosol transmission:
Respiratory Droplets vs. Aerosol Transmission
Definitions and Particle Size
The distinction hinges primarily on particle size, though this boundary is now recognized as more of a spectrum than a hard cutoff:
| Feature | Respiratory Droplets | Aerosols (Droplet Nuclei) |
|---|
| Size | > 5–10 µm diameter | < 5 µm (classically ≤ 6 µm) |
| Behavior in air | Fall rapidly (seconds–minutes); settle within ~3–6 feet | Remain suspended in air for prolonged periods; travel long distances |
| Evaporation | Less complete; retain liquid core | Evaporate quickly to dry nuclei; more resistant to desiccation |
| Deposition site | Conjunctivae, nasal mucosa, mouth | Upper AND lower respiratory tract (0.6–5 µm range penetrates deep) |
| Infectious range | Short (< 3–6 ft / ~1–2 m) | Can extend across a room or building |
A particle of 100 µm falls the height of a room in seconds; a 10 µm particle remains airborne ~20 minutes; smaller particles remain suspended even longer. When inhaled, particles ≥ 6 µm are trapped by nasal turbinate mucosa, while 0.6–5 µm particles deposit at various levels of the respiratory tract and are most efficient at initiating infection. — Sherris & Ryan's Medical Microbiology, 8th Ed.
How Each Is Generated
Both are produced by the same activities — coughing, sneezing, talking, singing, breathing — but the method and force of propulsion influences the size distribution. High-force events (coughing, sneezing) generate more large droplets, while normal breathing and speech also produce aerosols. Aerosol-generating medical procedures (intubation, bronchoscopy, suctioning, CPR) markedly increase small-particle output.
Transmission Mechanics
Droplet transmission:
- Source person generates large particles → propelled short distance → deposit directly onto mucous membranes of a close contact's eyes, nose, or mouth
- Does not require special air handling or negative pressure ventilation
- Examples: Bordetella pertussis, Group A Streptococcus, influenza virus, rhinovirus, Neisseria meningitidis
Airborne / aerosol transmission:
- Droplet nuclei remain suspended; can be transported by air currents within the same room or at longer distances
- Requires special ventilation: 6–12 air changes/hour, negative pressure isolation rooms, HEPA filtration
- Examples: Mycobacterium tuberculosis, measles virus, varicella-zoster virus
— Red Book 2021 (AAP)
The Spectrum Reality (Modern View)
The traditional binary droplet/airborne model is increasingly challenged. Key points:
- SARS-CoV-2 is transmitted by both small and large particle aerosols, making the dichotomy clinically important for COVID — surgical masks reduce large droplets; N95 respirators address fine aerosols. — Goldman-Cecil Medicine
- The 5 µm cutoff is physiologically arbitrary; particles across a wide size range can be infectious depending on pathogen, inoculum, and host factors
- Prolonged indoor exposure, poor ventilation, and crowded spaces all favor aerosol-mediated spread even for pathogens traditionally classified as "droplet-only"
- Morawska et al. (2023) argue that COVID-19 demonstrated how public health agencies underestimated airborne transmission, delaying appropriate guidance
Infection Control Implications
| Precaution Type | Indication | Key Measures |
|---|
| Droplet precautions | Influenza, pertussis, meningococcal | Surgical mask within 3–6 ft; single room; no special ventilation needed |
| Airborne precautions | TB, measles, varicella | N95 respirator (fit-tested); negative pressure room; HEPA filtration |
| Contact + airborne | SARS-CoV-2, MERS-CoV | N95 + eye protection + gown + gloves; airborne isolation room prioritized for aerosol-generating procedures |
Summary
The droplet vs. aerosol distinction is real and clinically actionable, but the boundary is a continuum rather than a strict cutoff. Particle size, settling velocity, environmental conditions (humidity, ventilation, UV exposure), and pathogen viability all interact. Modern evidence — particularly from COVID-19 — favors treating respiratory pathogens with a precautionary approach that accounts for both routes when transmission is uncertain.